Oligo Medic was founded in 2010 by biomaterials experts who have developed the first polysaccharide thermogelling implants for biomedical applications1, with a vision to provide minimally invasive solutions that fit seamlessly within the clinical workflow.
The company's leading technology platform2 is a gelling composition with the following fundamental characteristics:
- Biocompatible: it can be administered anywhere in the body without eliciting any adverse tissue reaction. Its pH and osmolarity are physiological, and it allows excellent cell viability.
- Thermogelling: Applied through standard needles, it solidifies at the temperature of the body. This allows it to be administered as an implant with minimal harm to the patient, bypassing the need for surgical implantation or e.g. UV crosslinking.
- Bioadhesive: Due to charges at the molecular level, it electrostatically adheres to mucous surfaces, allowing for a precise application at the intended location, bypassing the need for fibrin or other gluing material.
- Biodegradable: Once inside the body, it is slowly degraded into constituent molecules that are native to the human body.